Kosaku Murakami
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.
Journal: Immunological medicine
Published: August 28, 2026
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.
Journal: ESMO real world data and digital oncology
Published: August 08, 2026
Rheumatoid arthritis developing after mogamulizumab treatment in Sézary syndrome.
Journal: EULAR rheumatology open
Published: August 01, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.
Journal: Immunological medicine
Published: June 26, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.
Journal: Scandinavian journal of rheumatology
Published: June 19, 2026
Comprehensive management of immune-related adverse events: predictive strategies, mechanistic insights, and therapeutic approaches.
Journal: Immunological medicine
Published: April 30, 2026
A simple heart failure detection score for rheumatology practice: findings from the KURAMA cohort.
Journal: Rheumatology (Oxford, England)
Published: April 20, 2026
Unilateral High-Riding Vertebral Artery Associates With the Progression of Atlantoaxial Joint Degeneration in Patients With Rheumatoid Arthritis.
Journal: International journal of rheumatic diseases
Published: March 23, 2026
Association between biologic exposure and relapse incidence in relapsing polychondritis: a retrospective cohort study.
Journal: Rheumatology (Oxford, England)
Published: February 24, 2026
Autoantibody and disease control stability following mRNA COVID-19 vaccination in rheumatoid arthritis: an observational cohort study.
Journal: Scientific reports
Published: October 16, 2025
Strong inhibition of IL-6 signal is clinically and serologically effective in refractory adult-onset Still's disease.
Journal: Rheumatology (Oxford, England)
Published: October 07, 2025
Last Updated: 09/26/2026